Last 40 quarters of trend data · Healthcare · Vaccines & Infectious Disease
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 10.00 | 6.53 | 7.70 | 18.23 | 16.70 | 13.11 | 13.29 | 20.24 | 18.60 | 29.17 | 78.88 | 55.48 | 35.07 | 26.03 | 21.69 | 22.75 | 13.97 | 10.33 | 95.00 | 17.98 | 19.41 |
| — | -50.2% | -42.1% | -10.0% | -10.2% | -55.1% | -83.1% | -63.5% | -47.0% | +12.1% | +263.7% | +143.9% | +151.1% | +152.0% | -77.2% | +26.5% | -28.0% | -58.8% | +350.2% | -39.2% | -19.7% | |
| P/S Ratio | 0.84 | 0.61 | 0.64 | 0.79 | 0.81 | 0.91 | 0.82 | 0.68 | 0.64 | 0.84 | 0.64 | 0.73 | 1.11 | 0.97 | 2.19 | 2.49 | 2.02 | 1.75 | 2.19 | 2.58 | 2.84 |
| — | -32.9% | -21.9% | +16.6% | +26.5% | +7.9% | +27.8% | -7.2% | -42.3% | -13.3% | -70.6% | -70.7% | -45.0% | -44.5% | +0.1% | -3.6% | -28.9% | -33.6% | -23.9% | -11.6% | +10.6% | |
| P/B Ratio | 0.68 | 0.60 | 0.60 | 0.69 | 0.84 | 0.90 | 0.82 | 0.58 | 0.59 | 0.75 | 0.56 | 0.58 | 1.04 | 0.72 | 1.71 | 1.64 | 1.88 | 1.56 | 1.72 | 1.85 | 2.01 |
| — | -32.6% | -26.3% | +19.1% | +42.4% | +18.6% | +45.1% | -0.2% | -43.7% | +4.3% | -66.9% | -64.4% | -44.3% | -53.5% | -0.7% | -11.6% | -6.8% | -40.5% | -42.3% | -33.1% | -24.8% | |
| P/FCF | 8.57 | 4.39 | 11.15 | 23.15 | 5.36 | 6.64 | 16.38 | 14.01 | 3.05 | 7.01 | 5.26 | — | 25.76 | 21.84 | 33.33 | 23.39 | 16.43 | 11.82 | 8.94 | 73.99 | 35.84 |
| — | -33.8% | -31.9% | +65.2% | +75.6% | -5.3% | +211.1% | — | -88.1% | -67.9% | -84.2% | — | +56.8% | +84.8% | +273.0% | -68.4% | -54.2% | -58.7% | -47.7% | — | +156.1% | |
| EV / EBITDA | 8.23 | 6.32 | 7.35 | 10.06 | 8.91 | 8.16 | 7.94 | 9.28 | 7.35 | 8.96 | 8.57 | 12.68 | 12.74 | 11.69 | 14.20 | 15.94 | 12.01 | 8.79 | 19.97 | 14.18 | 15.37 |
| — | -22.6% | -7.5% | +8.3% | +21.3% | -8.9% | -7.3% | -26.8% | -42.3% | -23.4% | -39.6% | -20.4% | +6.1% | +33.0% | -28.9% | +12.3% | -21.9% | -36.2% | +48.8% | +30.5% | -0.8% | |
| EV / EBIT | 12.06 | 7.96 | 7.49 | 14.14 | 13.29 | 11.20 | 10.91 | 12.05 | 15.64 | 10.59 | 13.06 | 16.22 | 23.34 | 16.74 | 19.70 | 22.98 | 15.99 | 11.60 | 34.83 | 18.26 | 17.76 |
| — | -28.9% | -31.3% | +17.4% | -15.0% | +5.8% | -16.4% | -25.7% | -33.0% | -36.7% | -33.7% | -29.4% | +46.0% | +44.3% | -43.5% | +25.9% | -10.0% | -35.2% | +110.2% | +27.1% | -8.1% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 35.7% | 40.1% | 37.6% | 36.5% | 34.7% | 40.3% | 39.3% | 39.5% | 38.8% | 40.5% | 36.9% | 39.9% | 39.0% | 39.6% | 43.0% | 45.0% | 45.1% | 47.7% | 32.3% | 45.7% | 44.7% |
| — | -0.3% | -4.5% | -7.6% | -10.7% | -0.6% | +6.6% | -1.1% | -0.5% | +2.5% | -14.2% | -11.4% | -13.6% | -17.1% | +32.9% | -1.5% | +0.9% | +3.4% | -31.5% | +0.1% | +5.6% | |
| Operating Margin | 16.4% | 21.0% | 17.6% | 14.6% | 13.9% | 20.5% | 18.4% | 15.1% | 18.8% | 17.7% | 16.5% | 12.5% | 14.4% | 15.7% | 18.5% | 18.0% | 19.0% | 24.7% | 10.7% | 21.2% | 21.3% |
| — | +2.4% | -4.8% | -2.7% | -26.3% | +16.2% | +12.0% | +20.1% | +30.7% | +12.7% | -11.2% | -30.3% | -24.1% | -36.5% | +73.2% | -15.0% | -10.8% | +10.4% | -57.2% | +5.9% | +17.6% | |
| Net Margin | 5.3% | 9.3% | 8.2% | 4.3% | 5.0% | 6.8% | 6.2% | 3.3% | 3.5% | 2.9% | 0.8% | 1.3% | 3.2% | 3.7% | 10.1% | 11.0% | 10.1% | 19.8% | 2.3% | 14.4% | 14.8% |
| — | +36.1% | +32.8% | +28.4% | +42.0% | +136.1% | +658.2% | +153.8% | +10.3% | -22.7% | -91.9% | -88.0% | -68.8% | -81.1% | +339.7% | -23.9% | -31.5% | +90.3% | -83.1% | +45.8% | +41.2% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 4.8% | 2.3% | 1.9% | 1.0% | 1.3% | 1.7% | 1.5% | 0.7% | 0.8% | 0.6% | 0.2% | 0.3% | 0.7% | 0.8% | 1.9% | 1.9% | 2.3% | 4.4% | 0.4% | 2.5% | 3.1% |
| — | +39.2% | +32.0% | +35.9% | +54.4% | +163.8% | +714.8% | +158.0% | +19.3% | -17.4% | -90.7% | -85.3% | -69.6% | -82.6% | +333.0% | -25.4% | -26.3% | +64.7% | -87.3% | +4.8% | +7.1% | |
| ROA | 1.9% | 0.9% | 0.8% | 0.4% | 0.5% | 0.6% | 0.6% | 0.3% | 0.3% | 0.2% | 0.1% | 0.1% | 0.3% | 0.3% | 0.8% | 0.8% | 1.0% | 2.0% | 0.2% | 1.1% | 1.3% |
| — | +46.3% | +33.4% | +32.2% | +48.3% | +163.6% | +756.3% | +182.4% | +27.2% | -22.0% | -92.1% | -87.9% | -74.6% | -84.5% | +318.1% | -26.0% | -20.1% | +100.5% | -84.3% | +26.4% | +21.1% | |
| ROIC | 5.4% | 2.0% | 1.5% | 1.2% | 1.3% | 1.8% | 1.6% | 1.1% | 1.6% | 1.4% | 1.2% | 0.8% | 1.0% | 1.1% | 1.3% | 1.2% | 1.7% | 2.2% | 0.8% | 1.4% | 1.6% |
| — | +10.4% | -3.9% | +2.7% | -20.6% | +29.7% | +28.1% | +38.5% | +55.2% | +20.7% | -7.9% | -29.7% | -39.3% | -49.3% | +61.0% | -18.3% | +4.2% | +16.8% | -72.3% | -40.7% | -34.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.15 | 1.12 | 1.07 | 1.23 | 1.15 | 1.28 | 1.16 | 1.21 | 1.17 | 1.23 | 1.39 | 1.40 | 1.47 | 1.29 | 1.10 | 1.02 | 1.03 | 0.99 | 1.00 | 1.00 | 1.04 |
| — | -12.7% | -8.1% | +1.7% | -1.9% | +4.1% | -16.3% | -13.7% | -20.1% | -4.5% | +26.3% | +37.0% | +42.3% | +30.1% | +9.7% | +2.5% | -0.7% | -28.3% | -30.1% | +1375.7% | -19.2% | |
| Debt / EBITDA | 5.40 | 17.02 | 19.53 | 26.98 | 21.82 | 19.99 | 19.35 | 26.40 | 20.92 | 23.16 | 28.03 | 36.83 | 30.60 | 30.83 | 22.69 | 25.00 | 17.55 | 14.52 | 30.79 | 20.49 | 21.69 |
| — | -14.9% | +1.0% | +2.2% | +4.3% | -13.7% | -31.0% | -28.3% | -31.6% | -24.9% | +23.5% | +47.3% | +74.4% | +112.3% | -26.3% | +22.0% | -19.1% | -26.7% | +72.3% | +1797.5% | +1.9% | |
| Current Ratio | 2.51 | 2.33 | 2.37 | 2.47 | 2.51 | 2.48 | 2.64 | 2.60 | 2.66 | 2.26 | 1.68 | 2.22 | 2.64 | 2.48 | 1.69 | 1.98 | 2.37 | 2.93 | 2.86 | 2.75 | 3.92 |
| — | -6.2% | -10.0% | -4.8% | -5.4% | +9.8% | +56.8% | +16.8% | +0.8% | -8.8% | -0.3% | +12.5% | +11.2% | -15.4% | -41.2% | -28.0% | -39.6% | +11.6% | +6.8% | -4.3% | +41.6% | |
| Quick Ratio | 0.88 | 0.82 | 0.81 | 0.85 | 0.88 | 0.93 | 0.95 | 0.97 | 1.01 | 0.79 | 0.80 | 1.02 | 1.14 | 0.75 | 0.58 | 0.61 | 0.87 | 1.33 | 1.18 | 0.90 | 2.21 |
| — | -11.9% | -15.0% | -13.2% | -12.4% | +17.1% | +19.2% | -4.8% | -11.7% | +5.0% | +37.9% | +68.7% | +30.8% | -43.3% | -51.0% | -32.8% | -60.6% | +39.4% | +24.0% | -20.1% | +81.1% | |
| Interest Coverage | 1.98 | — | 5.33 | 1.81 | 1.69 | 2.27 | 2.35 | 1.91 | 14.27 | 1.82 | 1.33 | 1.42 | 1.22 | 1.66 | — | 3.48 | 3.31 | 19.58 | 1.93 | 16.19 | 30.76 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 40 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying GRFS stock.
Grifols, S.A.'s current P/E is 10.0x. The average P/E over the last 4 quarters is 12.3x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Grifols, S.A.'s current operating margin is 16.4%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Grifols, S.A.'s business trajectory between earnings reports.